| Matthew John O'shaughnessy, MD, PHD | |
|
6525 France Ave S Ste 200, Edina, MN 55435-2176 | |
| (952) 927-6501 | |
| (952) 653-1435 |
| Full Name | Matthew John O'shaughnessy |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 16 Years |
| Location | 6525 France Ave S Ste 200, Edina, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881867810 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 269142 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Abbott Northwestern Hospital | Minneapolis, MN | Hospital |
| Fairview Southdale Hospital | Edina, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Minnesota Urology Pa | 0840183984 | 67 |
| Allina Health System | 4587573613 | 3071 |
News Archive
Opexa Therapeutics, Inc., a company developing Tovaxin, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced results from further analysis of the double-blind, placebo-controlled, 52-week Phase IIb TERMS clinical study of 150 patients with Relapsing Remitting MS (RRMS).
Amid the COVID-19 chaos in many hospitals, emergency medicine physicians in seven cities around the country experienced rising levels of anxiety and emotional exhaustion, regardless of the intensity of the local surge, according to a new analysis led by UC San Francisco.
How messages sent within stem cells through a specific communication pathway can trigger the cells to specialize and become blood cells in humans, has been discovered by scientists of the McMaster Stem Cell and Cancer Research Institute.
Infants and young children living with HIV will finally have access to an improved formulation of an antiretroviral (ARV) treatment, following the U.S. Food and Drug Administration's tentative approval last week of lopinavir/ritonavir (LPV/r) oral pellets developed by the Indian generic company Cipla.
The New York Times on Sunday examined how Democrats - who for years "have been trying to stop the proliferation of doctor-owned hospitals in the belief that they drive up costs by encouraging doctors to order more procedures" - have moved to "impose new restrictions on these for-profit hospitals" as part of a Senate supplemental war appropriations bill, although they have "carved out exemptions for a few institutions represented by influential senators and well-connected lobbyists."
› Verified 6 days ago
| Entity Name | Minnesota Urology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912971912 PECOS PAC ID: 0840183984 Enrollment ID: O20040204000003 |
News Archive
Opexa Therapeutics, Inc., a company developing Tovaxin, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced results from further analysis of the double-blind, placebo-controlled, 52-week Phase IIb TERMS clinical study of 150 patients with Relapsing Remitting MS (RRMS).
Amid the COVID-19 chaos in many hospitals, emergency medicine physicians in seven cities around the country experienced rising levels of anxiety and emotional exhaustion, regardless of the intensity of the local surge, according to a new analysis led by UC San Francisco.
How messages sent within stem cells through a specific communication pathway can trigger the cells to specialize and become blood cells in humans, has been discovered by scientists of the McMaster Stem Cell and Cancer Research Institute.
Infants and young children living with HIV will finally have access to an improved formulation of an antiretroviral (ARV) treatment, following the U.S. Food and Drug Administration's tentative approval last week of lopinavir/ritonavir (LPV/r) oral pellets developed by the Indian generic company Cipla.
The New York Times on Sunday examined how Democrats - who for years "have been trying to stop the proliferation of doctor-owned hospitals in the belief that they drive up costs by encouraging doctors to order more procedures" - have moved to "impose new restrictions on these for-profit hospitals" as part of a Senate supplemental war appropriations bill, although they have "carved out exemptions for a few institutions represented by influential senators and well-connected lobbyists."
› Verified 6 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
Opexa Therapeutics, Inc., a company developing Tovaxin, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced results from further analysis of the double-blind, placebo-controlled, 52-week Phase IIb TERMS clinical study of 150 patients with Relapsing Remitting MS (RRMS).
Amid the COVID-19 chaos in many hospitals, emergency medicine physicians in seven cities around the country experienced rising levels of anxiety and emotional exhaustion, regardless of the intensity of the local surge, according to a new analysis led by UC San Francisco.
How messages sent within stem cells through a specific communication pathway can trigger the cells to specialize and become blood cells in humans, has been discovered by scientists of the McMaster Stem Cell and Cancer Research Institute.
Infants and young children living with HIV will finally have access to an improved formulation of an antiretroviral (ARV) treatment, following the U.S. Food and Drug Administration's tentative approval last week of lopinavir/ritonavir (LPV/r) oral pellets developed by the Indian generic company Cipla.
The New York Times on Sunday examined how Democrats - who for years "have been trying to stop the proliferation of doctor-owned hospitals in the belief that they drive up costs by encouraging doctors to order more procedures" - have moved to "impose new restrictions on these for-profit hospitals" as part of a Senate supplemental war appropriations bill, although they have "carved out exemptions for a few institutions represented by influential senators and well-connected lobbyists."
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew John O'shaughnessy, MD, PHD 6525 France Ave S Ste 200, Edina, MN 55435-2176 Ph: (952) 927-6501 | Matthew John O'shaughnessy, MD, PHD 6525 France Ave S Ste 200, Edina, MN 55435-2176 Ph: (952) 927-6501 |
News Archive
Opexa Therapeutics, Inc., a company developing Tovaxin, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced results from further analysis of the double-blind, placebo-controlled, 52-week Phase IIb TERMS clinical study of 150 patients with Relapsing Remitting MS (RRMS).
Amid the COVID-19 chaos in many hospitals, emergency medicine physicians in seven cities around the country experienced rising levels of anxiety and emotional exhaustion, regardless of the intensity of the local surge, according to a new analysis led by UC San Francisco.
How messages sent within stem cells through a specific communication pathway can trigger the cells to specialize and become blood cells in humans, has been discovered by scientists of the McMaster Stem Cell and Cancer Research Institute.
Infants and young children living with HIV will finally have access to an improved formulation of an antiretroviral (ARV) treatment, following the U.S. Food and Drug Administration's tentative approval last week of lopinavir/ritonavir (LPV/r) oral pellets developed by the Indian generic company Cipla.
The New York Times on Sunday examined how Democrats - who for years "have been trying to stop the proliferation of doctor-owned hospitals in the belief that they drive up costs by encouraging doctors to order more procedures" - have moved to "impose new restrictions on these for-profit hospitals" as part of a Senate supplemental war appropriations bill, although they have "carved out exemptions for a few institutions represented by influential senators and well-connected lobbyists."
› Verified 6 days ago
Erol Uke, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 4410 Sunnyside Rd, Edina, MN 55424 Phone: 952-926-0231 | |
Dr. Thomas Arthur Rivers, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 6525 France Ave S, Suite 200, Edina, MN 55435 Phone: 952-927-6501 Fax: 952-653-1435 | |
Dr. William Joseph Utz, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 6525 France Ave S, Suite 200, Edina, MN 55435 Phone: 952-927-6501 Fax: 952-653-1435 | |
Dr. Todd Daniel Fleming, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 6525 France Ave S, Suite 200, Edina, MN 55435 Phone: 952-927-6501 Fax: 952-653-1435 | |
Paul T Fadden, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 6525 France Ave S, Suite 200, Edina, MN 55435 Phone: 952-927-6501 Fax: 952-653-1435 | |
Stephen D Bennett, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 6363 France Ave S, #500, Edina, MN 55435 Phone: 952-920-7660 Fax: 952-920-2049 | |
Joseph Robert Nelson Zabell, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 6363 France Ave S Ste 500, Edina, MN 55435 Phone: 952-920-7660 |